HK1010095A1 - Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. - Google Patents
Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.Info
- Publication number
- HK1010095A1 HK1010095A1 HK98110925A HK98110925A HK1010095A1 HK 1010095 A1 HK1010095 A1 HK 1010095A1 HK 98110925 A HK98110925 A HK 98110925A HK 98110925 A HK98110925 A HK 98110925A HK 1010095 A1 HK1010095 A1 HK 1010095A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- byfree
- amedicament
- dehydroestrone
- radicals
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US793195P | 1995-12-04 | 1995-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1010095A1 true HK1010095A1 (en) | 1999-06-11 |
Family
ID=21728885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98110925A HK1010095A1 (en) | 1995-12-04 | 1998-09-24 | Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0778025B1 (sk) |
JP (1) | JPH09169650A (sk) |
KR (1) | KR100444002B1 (sk) |
CN (1) | CN1104900C (sk) |
AR (2) | AR005866A1 (sk) |
AT (1) | ATE263565T1 (sk) |
AU (1) | AU703814B2 (sk) |
BR (1) | BR9605777A (sk) |
CA (1) | CA2191835A1 (sk) |
CZ (1) | CZ289780B6 (sk) |
DE (1) | DE69632117T2 (sk) |
DK (1) | DK0778025T3 (sk) |
ES (1) | ES2215187T3 (sk) |
HK (1) | HK1010095A1 (sk) |
HU (1) | HUP9603329A3 (sk) |
IL (1) | IL119744A (sk) |
MX (1) | MX9606009A (sk) |
NO (1) | NO312654B1 (sk) |
NZ (1) | NZ299858A (sk) |
PT (1) | PT778025E (sk) |
SI (1) | SI0778025T1 (sk) |
SK (1) | SK154296A3 (sk) |
ZA (1) | ZA969923B (sk) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19723794A1 (de) * | 1997-06-06 | 1998-12-10 | Jenapharm Gmbh | Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität |
US9557325B2 (en) | 2003-06-09 | 2017-01-31 | Redox-Reactive Reagents Llc | Method of altering the binding specificity of proteins by oxidation-reduction reactions |
ATE518886T1 (de) | 2003-06-09 | 2011-08-15 | Redox Reactive Reagents L L C | Verfahren zur änderung der bindungsspezifität von plasmaproteinen durch oxidations- reduktionsreaktionen |
US7892751B2 (en) | 2003-06-09 | 2011-02-22 | Redox-Reactive Reagents Llc | Method of detecting or diagnosing of a neurodegenerative disease or condition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5210081A (en) * | 1992-02-26 | 1993-05-11 | American Home Products Corporation | Alkali metal 8,9-dehydroestrone sulfate esters |
DE4334823C2 (de) * | 1993-10-09 | 1998-09-17 | Schering Ag | Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen |
US5395831A (en) * | 1994-04-08 | 1995-03-07 | American Home Products Corporation | Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone |
DE19509729A1 (de) * | 1995-03-13 | 1996-09-19 | Schering Ag | 17-Difluormethylen-Estratriene |
-
1996
- 1996-11-25 AU AU71944/96A patent/AU703814B2/en not_active Ceased
- 1996-11-26 ZA ZA9609923A patent/ZA969923B/xx unknown
- 1996-11-27 AR ARP960105366A patent/AR005866A1/es not_active Application Discontinuation
- 1996-11-28 ES ES96308632T patent/ES2215187T3/es not_active Expired - Lifetime
- 1996-11-28 PT PT96308632T patent/PT778025E/pt unknown
- 1996-11-28 DE DE69632117T patent/DE69632117T2/de not_active Expired - Fee Related
- 1996-11-28 SI SI9630674T patent/SI0778025T1/xx unknown
- 1996-11-28 AT AT96308632T patent/ATE263565T1/de not_active IP Right Cessation
- 1996-11-28 EP EP96308632A patent/EP0778025B1/en not_active Expired - Lifetime
- 1996-11-28 DK DK96308632T patent/DK0778025T3/da active
- 1996-12-02 NZ NZ299858A patent/NZ299858A/en unknown
- 1996-12-02 MX MX9606009A patent/MX9606009A/es not_active IP Right Cessation
- 1996-12-02 CA CA002191835A patent/CA2191835A1/en not_active Abandoned
- 1996-12-02 BR BR9605777A patent/BR9605777A/pt not_active Application Discontinuation
- 1996-12-02 SK SK1542-96A patent/SK154296A3/sk unknown
- 1996-12-03 CZ CZ19963532A patent/CZ289780B6/cs not_active IP Right Cessation
- 1996-12-03 HU HU9603329A patent/HUP9603329A3/hu unknown
- 1996-12-03 KR KR1019960061345A patent/KR100444002B1/ko not_active IP Right Cessation
- 1996-12-03 CN CN96123342A patent/CN1104900C/zh not_active Expired - Fee Related
- 1996-12-03 IL IL11974496A patent/IL119744A/xx not_active IP Right Cessation
- 1996-12-03 JP JP8322539A patent/JPH09169650A/ja not_active Ceased
- 1996-12-03 NO NO19965165A patent/NO312654B1/no unknown
-
1998
- 1998-09-24 HK HK98110925A patent/HK1010095A1/xx not_active IP Right Cessation
-
2007
- 2007-03-19 AR ARP070101105A patent/AR059965A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO312654B1 (no) | 2002-06-17 |
BR9605777A (pt) | 1998-08-25 |
NZ299858A (en) | 2001-03-30 |
CN1158725A (zh) | 1997-09-10 |
KR970032870A (ko) | 1997-07-22 |
IL119744A (en) | 2003-01-12 |
EP0778025B1 (en) | 2004-04-07 |
NO965165D0 (no) | 1996-12-03 |
NO965165L (no) | 1997-06-05 |
CA2191835A1 (en) | 1997-06-05 |
CZ289780B6 (cs) | 2002-04-17 |
ZA969923B (en) | 1998-05-26 |
DK0778025T3 (da) | 2004-06-07 |
HUP9603329A3 (en) | 1998-01-28 |
MX9606009A (es) | 1997-08-30 |
ES2215187T3 (es) | 2004-10-01 |
SK154296A3 (en) | 1997-08-06 |
AR059965A2 (es) | 2008-05-14 |
CZ353296A3 (en) | 1997-08-13 |
SI0778025T1 (en) | 2004-08-31 |
DE69632117T2 (de) | 2004-08-26 |
JPH09169650A (ja) | 1997-06-30 |
KR100444002B1 (ko) | 2004-11-03 |
CN1104900C (zh) | 2003-04-09 |
AU7194496A (en) | 1997-06-12 |
DE69632117D1 (de) | 2004-05-13 |
HUP9603329A2 (en) | 1997-08-28 |
HU9603329D0 (en) | 1997-01-28 |
ATE263565T1 (de) | 2004-04-15 |
PT778025E (pt) | 2004-08-31 |
EP0778025A1 (en) | 1997-06-11 |
AR005866A1 (es) | 1999-07-21 |
IL119744A0 (en) | 1997-03-18 |
AU703814B2 (en) | 1999-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2639695A (en) | Novel uses of triplex forming oligonucleotides for the treatment of human diseases | |
ZA968957B (en) | Process for the preparation of dihaloazolopyrimidines. | |
NL1003813A1 (nl) | Inrichting voor de behandeling van luchtwegobstructies. | |
GR3036315T3 (en) | Indolinone compounds for the treatment of disease | |
ZA949344B (en) | Treatment of poultry. | |
ZA968481B (en) | Process for the preparation of 1,1,1,3,3-pentafluoropropane | |
ZA964298B (en) | Use of aryl-substituted cyclobutylalkylamines for the treatment of obesity. | |
ITTO940748A0 (it) | Condotto protesico particolarmente per il trattamento di patologie cardiovascolari. | |
ZA973622B (en) | Use of forms of hyaluronic acid (HA) for the treatment of cancer. | |
FI974640A (fi) | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit | |
EP1126850A4 (en) | TREATMENT OF CONDITIONS OF THE RETINA | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
AU3187595A (en) | Compounds for the treatment of restenosis | |
HK1038510A1 (en) | Use of neurotrophic factor stimulators for the treamtent of ophthalmic neurodegenerative diseases. | |
NO913117D0 (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
HK1010095A1 (en) | Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. | |
IL113057A0 (en) | Compositions for the treatment of dandruff | |
ZA200110539B (en) | Oxazinocarbazoles for the treatment of CNS diseases. | |
ZA966452B (en) | Process for the preparation of substituted aminocarbonyltriazolinones. | |
EP0755262A4 (en) | PNEUMOPATHY TREATMENT COMPOSITION | |
GB9516444D0 (en) | Process for the production of n,n-dimethyl-n'-phenylureas | |
EP0774260A4 (en) | REMEDY FOR CORNEAL AFFECTIONS | |
ZA9610761B (en) | Medical treatment. | |
IL118731A (en) | Process for the preparation of 2,2-dialkyl-arylidenecycloalkanones | |
AU6097394A (en) | Method for the treatment of respiratory disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20081128 |